You are here: Home » PTI Stories » National » News
Business Standard

Jubilant Life Sciences looks to buy specialty pharma biz in US

Press Trust of India  |  New Delhi 

Jubilant Life Sciences today said its subsidiary Jubilant Pharma will negotiate a potential of a specialty business in the US.

"The Board of Directors of Jubilant Pharma Ltd, a material wholly-owned subsidiary of the company in Singapore, has approved to negotiate a potential of a specialty pharma business in the United States using only internal accruals," Jubilant Life Sciences said in a filing.

The potential will be subject to due diligence, satisfactory agreements, etc and final approval of Jubilant Life Sciences.

It further said: "The proposed acquisition is a niche, profitable speciality pharma business with a strategic fit and is expected to provide competitive edge for JPL's existing business, if it materialises".

of Jubilant Life Sciences were trading 0.59 per cent up at Rs 790 apiece on

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, March 21 2017. 11:32 IST